J vs SCNI · P/E 36, rev $4.08B vs P/E 0.2, rev $1.3M
Jacobs Solutions Inc. (J) versus Scinai Immunotherapeutics Ltd (SCNI) — a side-by-side from cached financials, not a winner call.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Scinai Immunotherapeutics Ltd (SCNI) is a biotechnology company listed on NASDAQ.
Latest reported J revenue for 2026-06-26 was $4.08B. Net income was $136.6M. Revenue was down 41.7% from 2026-03-27 to 2026-06-26. J currently screens at market cap $14.40B and trailing P/E 36.0.
Latest reported SCNI revenue for 2025-12-31 was $1.3M. Net income was -$8.3M. Revenue was up 99.2% from 2024-12-31 to 2025-12-31. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
J currently screens at market cap $14.40B and trailing P/E 36.0. SCNI currently screens at market cap $1.8M and trailing P/E 0.2.
Not investment advice. Open the J and SCNI stock pages for the full models.
Not investment advice.